Topic: Biotech
Dr. Moira Gunn speaks with Dr. Anthony Smithyman, about antibiotics - once thought to be the great cure-all. Smithyman talks about the state of antibiotic resistance.
Dr. Moira Gunn speaks with Dr. Gerard Davis, the CEO of Catapult Genetics, who talks about genetics testing in the cattle industry, and Australia's Dr. Paul Fisher talks about mitochondrial diseases and the research he is undertaking to meet the challenge.
Dr. Moira Gunn speaks with the chair of ISAAA's board of directors, Dr. Clive James, about biotech agriculture. He confirms that the United States grows more biotech crops than any other nation.
On this week's BioIssue, David Ewing Duncan talks about Craig Venter, the American biologist and businessman who founded the Institute of Genomic Research.
On this Bio-Issue of the Week, David Ewing Duncan speaks with Dr. Moira Gunn about a familiar topic: having your DNA read. Duncan explains that -- like many things in the BioTech world -- there's more to it than that.
On BioTech Nation, Dr. Moira Gunn looks at pediatric biotech. Dr. Tom Anderson from Pediatric Bioscience talks about progress with autism and Asperger's Syndrome, and David Ewing Duncan presents the new scientific findings on coffee - big news... if you're a woman.
On BioTech Nation, Dr. Moira Gunn speaks with Dr. Jenny Harry, who talks about the latest developments in a semen-based prostate cancer test, while David Ewing Duncan talks about a longevity pill.
Dr. Moira Gunn speaks with Richard Morgan about what life may be like after a hundred years of biotech. Morgan explains we'll have gotten plenty right and plenty wrong.
On BioTech Nation, Dr. Moira Gunn speaks with Dr. Belinda Clarke, who talks about the latest in European thinking on genetically modified everything. Also, learn about wallabies in Australia that are helping in the fight against drug resistant bacteria.
On BioTech Nation, Dr. Moira Gunn takes a look at developments in heart surgery and heart transplants by talking to Dr. Tomas Kara, the Executive Director of the International Clinical Research Center, while David Ewing Duncan explains how a presidential administration might be labeled "anti-science."
